IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Review of Diabetic Studies

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.00

h-Index

2022-2023

 50

Rank

2022-2023

 9840

SJR

2022-2023

 0.528

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Review of Diabetic Studies
Abbreviation Rev. Diabet. Stud.
Publication Type Journal
Subject Area, Categories, Scope Internal Medicine (Q2); Medicine (miscellaneous) (Q2); Endocrinology (Q3); Endocrinology, Diabetes and Metabolism (Q3)
h-index 50
Overall Rank/Ranking 9840
SCImago Journal Rank (SJR) 0.528
Impact Score 1.00
Publisher Society for Biomedical Diabetes Research
Country Germany
ISSN 16140575, 16136071
Best Quartile Q2
Coverage History 2007-2022




About Review of Diabetic Studies


Review of Diabetic Studies is a journal covering the technologies/fields/categories related to Internal Medicine (Q2); Medicine (miscellaneous) (Q2); Endocrinology (Q3); Endocrinology, Diabetes and Metabolism (Q3). It is published by Society for Biomedical Diabetes Research. The overall rank of Review of Diabetic Studies is 9840. According to SCImago Journal Rank (SJR), this journal is ranked 0.528. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 50. The best quartile for this journal is Q2.

The ISSN of Review of Diabetic Studies journal is 16140575, 16136071. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Review of Diabetic Studies is cited by a total of 59 articles during the last 3 years (Preceding 2022).


Review of Diabetic Studies Impact IF 2022-2023


The Impact IF 2022 of Review of Diabetic Studies is 1.00, which is computed in 2023 as per its definition. Review of Diabetic Studies IF is decreased by a factor of 2.5 and approximate percentage change is -71.43% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Review of Diabetic Studies Impact IF 2023 Prediction


Impact IF 2022 of Review of Diabetic Studies is 1.00. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Review of Diabetic Studies. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.00
2021 3.50
2020 2.18
2019 1.88
2018 2.00
2017 2.15
2016 2.20
2015 1.95
2014 1.46

Review of Diabetic Studies h-index


  Table Setting

Review of Diabetic Studies has an h-index of 50. It means 50 articles of this journal have more than 50 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Review of Diabetic Studies ISSN


The ISSN of Review of Diabetic Studies is 16140575, 16136071. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Review of Diabetic Studies Rank and SCImago Journal Rank (SJR)


The overall rank of Review of Diabetic Studies is 9840. According to SCImago Journal Rank (SJR), this journal is ranked 0.528. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Review of Diabetic Studies by Year


Year SJR
2023/2024 Coming Soon
2022 0.528
2021 0.650
2020 0.701
2019 1.021
2018 0.789
2017 0.915
2016 0.728
2015 0.799
2014 0.887

Ranking of Review of Diabetic Studies by Year


Year Ranking
2023/2024 Coming Soon
2022 9840
2021 7499
2020 7110
2019 4199
2018 5987
2017 4942
2016 6470
2015 5927
2014 5083

Review of Diabetic Studies Publisher


Table Setting

Review of Diabetic Studies is published by Society for Biomedical Diabetes Research. It's publishing house is located in Germany. Coverage history of this journal is as following: 2007-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Review of Diabetic Studies is Rev. Diabet. Stud.. This abbreviation ('Rev. Diabet. Stud.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Review of Diabetic Studies


If your research field is/are related to Internal Medicine (Q2); Medicine (miscellaneous) (Q2); Endocrinology (Q3); Endocrinology, Diabetes and Metabolism (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Review of Diabetic Studies?

Review of Diabetic Studies latest impact IF is 1.00. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.50 (2021) and 1.00 (2022), respectively, in the last 9 years. Moreover, its average IS is 2.04 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Review of Diabetic Studies?

The Review of Diabetic Studies has an SJR (SCImago Journal Rank) of 0.528, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.021 in 2019 and the lowest being 0.528 in 2022. Furthermore, the average SJR of the Review of Diabetic Studies over the previous 9-year period stands at 2.04.


What's the latest h-index of the Review of Diabetic Studies?

The latest h-index of the Review of Diabetic Studies is 50.


Who's the publisher of the Review of Diabetic Studies?

The Review of Diabetic Studies is published by the Society for Biomedical Diabetes Research, with its country of publication being the Germany.


What's the current ranking of the Review of Diabetic Studies?

The Review of Diabetic Studies is currently ranked 9840 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4199 in 2019 and its lowest position of 9840 in 2022.


What's the abbreviation or short name for the Review of Diabetic Studies?

The standard ISO4 abbreviation for the Review of Diabetic Studies is Rev. Diabet. Stud..


Is the "Review of Diabetic Studies" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Review of Diabetic Studies is classified as a journal that the Society for Biomedical Diabetes Research publishes.


What's the scope or major areas of the Review of Diabetic Studies?

The Review of Diabetic Studies encompasses the following areas:

  • Internal Medicine
  • Medicine (miscellaneous)
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Review of Diabetic Studies?

The Review of Diabetic Studies is assigned the following International Standard Serial Numbers (ISSN): 16140575, 16136071.


What's the best quartile of the Review of Diabetic Studies?

The best quartile for the Review of Diabetic Studies is Q2 (2022).


What's the coverage history of the Review of Diabetic Studies?

The Review of Diabetic Studies coverage history can be summarized as follows: 2007-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 10343 Vilnius Gediminas Technical University 45 2.81
Applied Ecology and Environmental Research journal 17545 Corvinus University of Budapest 38 0.74
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Journal of Competition Law and Economics journal 14815 Oxford University Press 29 0.72
CESifo Economic Studies journal 14012 Oxford University Press 32 1.70
Entrepreneurship Theory and Practice journal 338 Wiley-Blackwell 185 12.75
Materials Research journal 14791 Universidade Federal de Sao Carlos 65 1.62
Canadian Journal of Education journal 17961 Canadian Society for the Study of Education (CSSE) 41 0.39

Check complete list




Year wise Impact Score (IS) of Review of Diabetic Studies

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.00
2021 3.50
2020 2.18
2019 1.88
2018 2.00
2017 2.15
2016 2.20
2015 1.95
2014 1.46



Top Journals/Conferences in Internal Medicine

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

JAMA Internal Medicine
American Medical Association | United States

Annals of Internal Medicine
American College of Physicians | United States

Diabetologia
Springer Verlag | Germany

Lancet Regional Health - Americas, The
Elsevier Ltd. | United Kingdom

Journal of Internal Medicine
Wiley-Blackwell Publishing Ltd | United Kingdom

JHEP Reports
Elsevier BV | Netherlands

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Endocrinology

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All

Top Journals/Conferences in Endocrinology, Diabetes and Metabolism

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Diabetologia
Springer Verlag | Germany

Metabolism: Clinical and Experimental
W.B. Saunders Ltd | United Kingdom

Obesity Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Diabetes
American Diabetes Association Inc. | United States

Cytokine and Growth Factor Reviews
Elsevier BV | United Kingdom

See All